drugset / Trial / NCT03329443
The Effect of Spironolactone on Acute Kidney Injury in Patients Undergoing Coronary Angiography
Phase 2
Completed
490 enrolled
Alhasan Mujtaba Abdul-Wahid
Ministry of Health-Basra Health Directorate-Al-Sader Teaching Hospital · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
an interventional study to measure the possible effects of spironolactone ( an aldosterone antagonist) on the incidence of acute kidney injury after coronary angiography
Timeline
- Start
- 2017-09-01
- Primary completion
- 2018-09-01
- Completion
- 2018-09-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Spironolactone | Small molecule | 200 mg | — |